Search

everythinglearnresearchcommunity

for

Search:↓

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Folliculin deficiency causes problems with cell division and positioning due to disrupted RhoA signaling and interaction with p0071.

MicroRNA-21 could help diagnose and treat skin fibrosis.

Liver damage in PCOS is linked to iron overload and cell death due to the miR-761-hepcidin/GPX4 pathway.

Keratin 79 is linked to liver damage and may help diagnose liver diseases.

The zinc-coordinated nanogel therapy speeds up wound healing after pancreas surgery by balancing metabolism and fighting bacteria.

Turning scar-forming cells into fat cells can reduce scarring.

N-acetylcysteine may help treat uterine and placental issues in PCOS.

The patient has frontal fibrosing alopecia (FFA).

A baby was diagnosed with IFAP syndrome due to a new genetic mutation, showing severe skin and developmental issues.

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Diabetes and necrotizing fasciitis together can be deadly.

Verteporfin treatment in mice led to complete skin healing without scarring.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

Gefitinib can cause rare scarring hair loss.

Topical rapamycin may effectively treat fibrous papules on the face.

Genetic testing can help diagnose skin conditions but needs more research for full effectiveness.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

Transferrin receptor 1 is essential for normal function in the intestines, pancreas, and skin.

Hair transplants can trigger a rare scarring hair loss that is hard to treat.

These hair loss conditions might be part of a spectrum, not separate issues.

New treatments targeting fibrosis could improve urinary symptoms in BPH.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

Unique fat cells near fibrotic areas contribute to systemic sclerosis progression.

PCL nanoscaffold-based liver spheroids are effective for drug screening and studying liver toxicity.

Wedelolactone may help treat lung fibrosis by reducing inflammation and lung damage.